RO127627B1 - Product for eliminating the effects of menopause installation - Google Patents
Product for eliminating the effects of menopause installation Download PDFInfo
- Publication number
- RO127627B1 RO127627B1 ROA201001260A RO201001260A RO127627B1 RO 127627 B1 RO127627 B1 RO 127627B1 RO A201001260 A ROA201001260 A RO A201001260A RO 201001260 A RO201001260 A RO 201001260A RO 127627 B1 RO127627 B1 RO 127627B1
- Authority
- RO
- Romania
- Prior art keywords
- parts
- product
- menopause
- effects
- installation
- Prior art date
Links
- 230000000694 effects Effects 0.000 title claims abstract description 23
- 230000009245 menopause Effects 0.000 title claims abstract description 23
- 238000009434 installation Methods 0.000 title claims abstract description 10
- 241000196324 Embryophyta Species 0.000 claims abstract description 13
- 244000235659 Rubus idaeus Species 0.000 claims abstract description 13
- 244000019459 Cynara cardunculus Species 0.000 claims abstract description 12
- 235000019106 Cynara scolymus Nutrition 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000002020 sage Nutrition 0.000 claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 8
- 235000019441 ethanol Nutrition 0.000 claims abstract description 7
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 6
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 6
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 6
- 235000015197 apple juice Nutrition 0.000 claims abstract description 6
- 235000012907 honey Nutrition 0.000 claims abstract description 6
- 235000017309 Hypericum perforatum Nutrition 0.000 claims abstract description 5
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 4
- 235000002912 Salvia officinalis Nutrition 0.000 claims abstract description 4
- 235000010841 Silybum marianum Nutrition 0.000 claims abstract description 4
- 240000005592 Veronica officinalis Species 0.000 claims abstract description 4
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 4
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims abstract description 4
- 244000272459 Silybum marianum Species 0.000 claims abstract description 3
- 235000010465 Veronica officinalis Nutrition 0.000 claims abstract description 3
- 235000002532 grape seed extract Nutrition 0.000 claims abstract description 3
- 241000282994 Cervidae Species 0.000 claims description 10
- 230000009471 action Effects 0.000 claims description 3
- 241001071795 Gentiana Species 0.000 claims description 2
- 244000178870 Lavandula angustifolia Species 0.000 claims description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 2
- 230000001914 calming effect Effects 0.000 claims description 2
- 230000001089 mineralizing effect Effects 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 241000282465 Canis Species 0.000 claims 1
- 241000546188 Hypericum Species 0.000 claims 1
- 235000011483 Ribes Nutrition 0.000 claims 1
- 241000220483 Ribes Species 0.000 claims 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims 1
- 210000000614 rib Anatomy 0.000 claims 1
- 244000042664 Matricaria chamomilla Species 0.000 abstract description 9
- 235000007232 Matricaria chamomilla Nutrition 0.000 abstract description 9
- 235000016520 artichoke thistle Nutrition 0.000 abstract description 8
- 235000007866 Chamaemelum nobile Nutrition 0.000 abstract description 7
- 244000281247 Ribes rubrum Species 0.000 abstract description 7
- 235000016911 Ribes sativum Nutrition 0.000 abstract description 7
- 235000002355 Ribes spicatum Nutrition 0.000 abstract description 7
- 241000219094 Vitaceae Species 0.000 abstract description 6
- 235000021021 grapes Nutrition 0.000 abstract description 6
- 235000016897 Ribes triste Nutrition 0.000 abstract description 5
- 244000141009 Hypericum perforatum Species 0.000 abstract description 4
- 235000011034 Rubus glaucus Nutrition 0.000 abstract description 3
- 240000003409 Gentiana lutea Species 0.000 abstract 2
- 235000002873 Gentiana lutea Nutrition 0.000 abstract 2
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015463 Lycium carolinianum Nutrition 0.000 abstract 1
- 241000109365 Rosa arkansana Species 0.000 abstract 1
- 235000005066 Rosa arkansana Nutrition 0.000 abstract 1
- 240000008530 Rosa canina Species 0.000 abstract 1
- 235000000539 Rosa canina Nutrition 0.000 abstract 1
- 241000320380 Silybum Species 0.000 abstract 1
- 235000005545 Veronica americana Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 description 46
- 238000011282 treatment Methods 0.000 description 14
- 230000006870 function Effects 0.000 description 12
- 230000008030 elimination Effects 0.000 description 9
- 238000003379 elimination reaction Methods 0.000 description 9
- -1 holozides Chemical compound 0.000 description 7
- 235000021013 raspberries Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000000762 glandular Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000000395 remineralizing effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- YXEZXGJYPKMKEJ-UHFFFAOYSA-N Gentianin Natural products C=Cc1cc2CCOC(=O)c2cn1 YXEZXGJYPKMKEJ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000218231 Moraceae Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229950009125 cynarine Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- XOXYHGOIRWABTC-UHFFFAOYSA-N gentisin Chemical compound C1=C(O)C=C2C(=O)C3=C(O)C=C(OC)C=C3OC2=C1 XOXYHGOIRWABTC-UHFFFAOYSA-N 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 description 2
- 229940005608 hypericin Drugs 0.000 description 2
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical class C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Chemical class C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- ZXFNOEJFYLQUSB-UHFFFAOYSA-N (2-methyl-4-phenylbutan-2-yl) acetate Chemical compound CC(=O)OC(C)(C)CCC1=CC=CC=C1 ZXFNOEJFYLQUSB-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N 3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-3,4-dihydro-2H-1-benzopyran-4-one Chemical compound C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Chemical class CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 description 1
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical compound CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 1
- 241001233914 Chelidonium majus Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- ZTDFZLVUIVPZDU-QGNHJMHWSA-N Cnicin Chemical compound OC[C@H](O)C(=C)C(=O)O[C@H]1CC(/C)=C/CC\C(CO)=C\[C@H]2OC(=O)C(=C)[C@@H]21 ZTDFZLVUIVPZDU-QGNHJMHWSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000958526 Cuon alpinus Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000195950 Equisetum arvense Species 0.000 description 1
- 239000005768 Equisetum arvense L. Substances 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- DUAGQYUORDTXOR-GPQRQXLASA-N Gentiopicrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)C2=CCOC(=O)C2=CO1 DUAGQYUORDTXOR-GPQRQXLASA-N 0.000 description 1
- DUAGQYUORDTXOR-WULZUDSJSA-N Gentiopicrin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)C=2C(C(=O)OCC=2)=CO1 DUAGQYUORDTXOR-WULZUDSJSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000229143 Hippophae Species 0.000 description 1
- 235000003935 Hippophae Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000017945 Matricaria Nutrition 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Chemical class OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 235000005291 Rumex acetosa Nutrition 0.000 description 1
- 244000137827 Rumex acetosa Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241001511915 Symphora Species 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-N Tyramine Natural products NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 244000047670 Viola x wittrockiana Species 0.000 description 1
- 235000004031 Viola x wittrockiana Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Chemical class 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical class OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000567 anti-anemic effect Effects 0.000 description 1
- 230000002456 anti-arthritic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000001390 anti-relaxing effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Chemical class C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229930008380 camphor Chemical class 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- PMRJYBALQVLLSJ-UHFFFAOYSA-N chamazulene Natural products CCC1=CC2=C(C)CCC2=CC=C1 PMRJYBALQVLLSJ-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Chemical class C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Chemical class OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Chemical class CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000015091 medicinal tea Nutrition 0.000 description 1
- 231100000551 menstrual abnormality Toxicity 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000017802 other dietary supplement Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000590 phytopharmaceutical Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229920002414 procyanidin Chemical class 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003236 psychic effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Chemical class OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Chemical class CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- CYGIJEJDYJOUAN-JSGXPVSSSA-N silydianin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@H]3C=C([C@@H]4[C@@](C3=O)(O)OC[C@@H]42)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-JSGXPVSSSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-O tyraminium Chemical compound [NH3+]CCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-O 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical class CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Chemical class 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Invenția se referă la un produs fitoterapeutic pentru eliminarea efectelor cauzate de instalarea menopauzei, cu acțiune calmantă, vitaminizantă, mineralizantă și detoxifiantă, pentru utilizare fitofarmaceutică.The invention relates to a phytotherapeutic product for eliminating the effects caused by the installation of menopause, with a soothing, vitaminizing, mineralizing and detoxifying action, for phytopharmaceutical use.
Literatura de specialitate a tratamentelor efectuate pentru eliminarea efectelor cauzate de instalarea menopauzei cu ajutorul produselor fitoterapeutice menționează:The specialty literature of the treatments performed to eliminate the effects caused by the installation of menopause with the help of herbal products mention:
RO 116947 B se referă la un ceai medicinal pentru afecțiuni ale aparatului genital feminin, recomandat pentru adolescente și femei în perioada de vârstă 12...15 ani și între 45 și 50 ani, pentru dismenoree, amenoree, metroragii și tulburări de menopauză, constituit din 10... 15 părți Herba Bursaepastoris - Traista ciobanului, 15...20 părți Herba Alchemillae Crețișoară, 5...10 părți Herba Hyperici - Sunătoare, 5...10 părți Herba Millefolii - Coada șoricelului, 15...25 părți Herba Leonuri - Talpa gâștii, 10...15 părți Folium Salviae - Frunze de Salvie, 10...15 părți Herba Menthae aquaticae- Izmă broaștei și 10...15 părți Radix Gelrădăcină de Cernețel, părțile fiind exprimate în greutate;RO 116947 B refers to a medicinal tea for disorders of the female genital tract, recommended for adolescents and women between the ages of 12 ... 15 years and between 45 and 50 years, for dysmenorrhea, amenorrhea, metrorrhagia and menopause disorders, constituted from 10 ... 15 parts Herba Bursaepastoris - Shepherd's Traitor, 15 ... 20 parts Herba Alchemillae Crețișooar, 5 ... 10 parts Herba Hyperici - Stinging, 5 ... 10 parts Herba Millefolii - Tail of the mouse, 15 ... 25 parts Herba Lions - goose soles, 10 ... 15 parts Folium Salviae - Sage leaves, 10 ... 15 parts Herba Menthae aquaticae- Frog Izmă and 10 ... 15 parts Radix Gelrădăcina de Cernețel, parts being expressed by weight ;
RO 120529 B1 descrie o compoziție antioxidantă pe bază de extracte naturale, pentru tratarea psoriazisului, ce constă în aceea că aceasta cuprinde fiavonoide, terpenoide, alantoină și derivați antracenici, extrase la o temperatură cuprinsă între 30 și 60°C, din plantele: Arctium lappa, Rumex acetosa, Urtica dioica, Viola tricolor, Calendula officinalis, Achillea millefolium, Equisetum arvense, Chelidonium majus, Salvia officinalis, Hypericum perforatum, Chamomillae flos, Borago officinalis, Cynara scolymus, semințe de strugure negru, Gallium molluga, Aristolochia clematitis, Symphytum officinalis și Roșa centifolia, astfel alese, încât raportul dintre antioxidanț/antifungic/ cicatrizant/antihepatic/ diuretic/ toniclimfatic/antiinflamator/relaxant nervos să fie: 0...3 : 0...3 : 0...3 : 0...1 : 0...1 : 0...1 : 0...1 :RO 120529 B1 describes an antioxidant composition based on natural extracts, for the treatment of psoriasis, which consists in that it contains fiavonoids, terpenoids, allantoin and anthracene derivatives, extracted at a temperature between 30 and 60 ° C, from plants: Arctium lappa , Rumex acetosa, Urtica dioica, Viola tricolor, Calendula officinalis, Achillea millefolium, Equisetum arvense, Chelidonium majus, Salvia officinalis, Hypericum perforatum, Chamomillae flos, Borago officinalis, Cynara scolymus, black grape seed, Gallium mollugais, Symphony molluga, Arist molluga, Symphora and Roşa centifolia, so chosen that the ratio of antioxidant / antifungal / healing / antihepatic / diuretic / tonic-lymphatic / anti-inflammatory / relaxing nerve is: 0 ... 3: 0 ... 3: 0 ... 3: 0 .. .1: 0 ... 1: 0 ... 1: 0 ... 1:
0...3;0 ... 3;
R0 122802 B1 prezintă o compoziție fitoterapeutică, destinată reechilibrării funcțiilor hepatobiliare, în afecțiuni cronice ale ficatului, ce constă în aceea că este constituită dinR0 122802 B1 presents a phytotherapeutic composition, intended to rebalance the hepatobiliary functions, in chronic liver diseases, consisting of the fact that it consists of
30...70% pulbere degresată de Hippophae fructus, 15...35% pulbere degresată de Cardui mariani fructus, 20...40% extract de Cynaria scolimus, 0,2...1 % ulei volatil de Rosmarinii aetheroleum, 0,1 ...0,8% ulei volatil de Foeniculiaetheroleum și/sau 0,1 ...0,5% ulei volatil de Basillici aetheroleum sau 0,1 ...0,5% ulei volatil de Thymi vulgaris aetheroleum și excipienți acceptabili farmaceutic.30 ... 70% skimmed powder of Hippophae fructus, 15 ... 35% skimmed powder of Cardui mariani fructus, 20 ... 40% Cynaria scolimus extract, 0.2 ... 1% volatile oil of Rosemary aetheroleum, 0.1 ... 0.8% volatile Foeniculiaetheroleum oil and / or 0.1 ... 0.5% volatile Basilica aetheroleum oil or 0.1 ... 0.5% volatile Thymi vulgaris aetheroleum oil and pharmaceutically acceptable excipients.
Alte produse utilizate pentru eliminarea efectelor menopauzei sunt constituite din tratamente hormonale de substituție și protecție contraceptivă, și cuprind de la 23 la 26 forme combinate de dozare, fiecare conținând un estrogen și un progesteron, sub formă de pilule sau comprimate (în doză de 2...5), ce trebuie administrate zilnic.Other products used to eliminate the effects of menopause are hormone replacement therapy and contraceptive protection, and include 23 to 26 combined dosage forms, each containing estrogen and progesterone, in pill or tablet form (in 2 doses). ..5), which must be administered daily.
Aceste produse au următoarele dezavantaje: nu acționează asupra cauzei apariției menopauzei, ci asupra efectelor acestora, prin introducerea de hormoni, ceea ce nu face decât să mențină o stare temporară de echilibru, și după eliminarea hormonilor, efectul trece; dacă dozajul se greșește, se pot obține unele efecte nedorite; acest tratament este dificil și poate fi aplicat doar de către medicii specialiști.These products have the following disadvantages: they do not act on the cause of the onset of menopause, but on their effects, by introducing hormones, which only maintains a temporary state of balance, and after the elimination of hormones, the effect passes; if the dosage is wrong, some undesirable effects can be obtained; this treatment is difficult and can only be applied by specialist doctors.
Produsul conform invenției lărgește gama de produse fitoterapeutice pentru stimularea funcției gonadelor, dar și a întregului organism, și valorifică, în scop terapeutic, specii de plante autohtone.The product according to the invention broadens the range of herbal products to stimulate the function of the gonads, but also of the whole organism, and exploits, for therapeutic purposes, native plant species.
Problema tehnică, obiectivă, pe care urmărește să o rezolve invenția, constă în stimularea glandulară și eliminarea efectelor cauzate de instalarea menopauzei, fiind totodată calmant, revitalizant, remineralizant și detoxifiant.The technical, objective problem that the invention seeks to solve is the glandular stimulation and elimination of the effects caused by the installation of menopause, while being soothing, revitalizing, remineralizing and detoxifying.
Soluția tehnică la această problemă constă în aceea că se asociază, într-o compoziție fitoterapeutică, un amestec de plante medicinale, atent selecționate.The technical solution to this problem is that it is associated, in a phytotherapeutic composition, a mixture of medicinal plants, carefully selected.
RO 127627 Β1RO 127627 Β1
Produsul fitoterapeutic, conform invenției, este constituit din: 7...13 părți Gentiana 1 Iuțea, 7...13 părți Cynara scolymus, 5...10 părți Lavandula angustifolia, 6...9 părți Roșa canina, 7...11 părți Hippophae rhamnoides, 8...13 părți Matricaria charmomilla, 5...8 părți 3 Semen Vitis vinifera, 7... 13 părți Hypericumperforatum, 7... 13 părți Veronica officinalis, 5...7 părți Salvia officinalis, 7...9 părți Silybum marianum, 5...9 părți extract din coarne de cerb, 5The phytotherapeutic product, according to the invention, consists of: 7 ... 13 parts Gentiana 1 Iuțea, 7 ... 13 parts Cynara scolymus, 5 ... 10 parts Lavandula angustifolia, 6 ... 9 parts Red dog, 7. .. .11 parts Hippophae rhamnoides, 8 ... 13 parts Matricaria charmomilla, 5 ... 8 parts 3 Semen Vitis vinifera, 7 ... 13 parts Hypericumperforatum, 7 ... 13 parts Veronica officinalis, 5 ... 7 parts Salvia officinalis, 7 ... 9 parts Silybum marianum, 5 ... 9 parts deer horn extract, 5
6...9 părți Rubus idaeus, 7...9 părți Ribes rubrum, eventual împreună cu miere în proporții egale sau cu 20...25 părți suc de mere sau 20...25 părți alcool etilic de 5. ..8°, pentru plante, 7 părțile fiiind exprimate în greutate, iar pentru lichide, în volume.6 ... 9 parts Rubus idaeus, 7 ... 9 parts Ribes rubrum, possibly together with honey in equal proportions or with 20 ... 25 parts apple juice or 20 ... 25 parts ethyl alcohol of 5. ... 8 °, for plants, 7 parts being expressed by weight, and for liquids, in volumes.
Produsul conform invenției prezintă următoarele avantaje: 9The product according to the invention has the following advantages: 9
- acționează asupra glandelor, stimulând activitatea acestora și eliminând efectele menopauzei; 11- acts on the glands, stimulating their activity and eliminating the effects of menopause; 11
- acționează și asupra sistemului nervos central, detensionându-l;- It also acts on the central nervous system, relaxing it;
- orice cantitate sau dozaj al produsului ingerat nu produce tulburări, produsul poate 13 fi administrat de oricine;- any quantity or dosage of the ingested product does not cause disturbance, the product may be administered by anyone;
- este în același timp detoxifiant, vitaminizant, antitumoral și remineralizant, ajutând 15 organismul să reintre în funcție normală;- it is at the same time detoxifying, vitaminizing, antitumor and remineralizing, helping 15 the body to return to normal function;
- acționează la reglarea funcției ficatului și a hipofizei, obținându-se rezultate notabile 17 în reactivarea echilibrului general al organismului.- It acts to regulate the function of the liver and the pituitary gland, obtaining remarkable results 17 in reactivating the general balance of the body.
Se prezintă, în continuare, un exemplu concret de realizare a invenției. 19The following is a concrete example of embodiment of the invention. 19
Exemplu. Se cântăresc următoarele plante medicinale, după cum urmează: 10 g ghințură, 10 g anghinare, 6 g măceșe, 7 g cătină, 8 g mușețel, 7 g sâmburi de struguri negri, 21 10 g sunătoare, 9 g ventrilică, 5 g salvie, 7 g armurariu, 7 g extract din coarne de cerb, 7 g zmeur și 7 g coacăze roșii, eventual miere în proporții egale. 23Example. Weigh the following medicinal plants, as follows: 10 g acorns, 10 g artichokes, 6 g mulberries, 7 g sea buckthorn, 8 g chamomile, 7 g black grape seeds, 21 10 g sound, 9 g ventricular, 5 g sage, 7 g armory, 7 g deer horn extract, 7 g raspberries and 7 g red currants, possibly honey in equal proportions. 2. 3
Produsul pulverulent se obține astfel: plantele alese se lasă la uscat, după care se fragmentează până la dimensiuni de 0,1...0,2 mm, apoi se amestecă într-un malaxor, iar 25 materia pulverulentă de culoare verzuie, astfel obținută, se încapsulează sau se ambalează în sticluțe sau cutii. 27The powdery product is obtained as follows: the selected plants are left to dry, then fragment to a size of 0.1 ... 0.2 mm, then mixed in a mixer, and 25 powdery green matter, thus obtained , is encapsulated or packaged in bottles or boxes. 27
Pulberea poate fi administrată ca atare, ambalată în sticluțe cu dop filetat, sau sub formă capsulată sau sticle de 500 ml, care se vor ambala în cutii de carton. Controlul 29 materiilor respectă normele de calitate din Farmacopeea Europeană.The powder can be administered as such, packaged in bottles with a threaded stopper, or in capsule form or 500 ml bottles, which will be packed in cardboard boxes. The control of the 29 subjects complies with the quality standards of the European Pharmacopoeia.
Doza apreciată ca fiind eficientă, conform testărilor preliminare, a fost de 4...10 31 capsule pe zi. Administrarea s-a făcut după mese. Pentru potențarea rezultatelor, capsulele sau o linguriță din produsul pulverulent se iau cu câte o linguriță de miere. 33The dose considered to be effective, according to preliminary tests, was 4 ... 10 31 capsules per day. The administration was done after meals. To enhance the results, the capsules or a teaspoon of the powdered product are taken with one teaspoon of honey. 33
Se poate folosi altă variantă a acestei rețete, cu miere sau ca extract în alcool, în situația în care este greu de suportat ca gust. Există și posibilitatea de obținere a produsului 35 cu suc de mere sau ca biter în prezența alcoolului etilic de 5...8°.Another variant of this recipe can be used, with honey or as an extract in alcohol, in cases where it is difficult to tolerate as a taste. There is also the possibility of obtaining the product 35 with apple juice or as a mixer in the presence of ethyl alcohol of 5 ... 8 °.
în cazul unui macerat în suc de mere, se introduce produsul pulverulent, împreună 37 cu sucul de mere, într-o incintă prevăzută cu un amestecător și un aparat de menținere a temperaturii constante, între 12 și 18°C, se amestecă timp de 4 min, se introduce un 39 conservant, de obicei, benzoat de sodiu, în concentrație de 0,01...0,02 părți, după care se îmbuteliază în sticle. 41In the case of a maceration in apple juice, the powdered product is introduced, together with 37 with the apple juice, in a chamber provided with a mixer and a constant temperature keeping device, between 12 and 18 ° C, mixing for 4 min, a preservative is introduced, usually sodium benzoate, in a concentration of 0.01 ... 0.02 parts, after which it is bottled in bottles. 41
Produsul cu alcool se poate obține asemănător cu obținerea unui biter. Astfel, se introduc plantele uscate într-o incintă cu alcool de 50°, se lasă la macerat, timp de 3...5 zile, 43 după care se extrag plantele, se filtrează lichidul obținut și se îmbuteliază. Doza apreciată, ca fiind eficientă, conform testărilor preliminare, a fost de maximum 100 ml/zi, repartizate în 45 porții de câte 25 ml, la fiecare 3...4 h. în continuare, este prezentată pe larg invenția.The alcohol product can be obtained in the same way as a bitumen. Thus, the dried plants are introduced into a 50 ° alcohol chamber, left to macerate for 3 to 5 days, 43 after which the plants are extracted, the obtained liquid is filtered and bottled. The estimated dose, as effective, according to the preliminary tests, was of maximum 100 ml / day, distributed in 45 portions of 25 ml each, every 3 ... 4 h. Below, the invention is widely presented.
RO 127627 Β1RO 127627 Β1
Produsul fitoterapeutic, conform invenției, se bazează pe substanțe active, naturale, existente în plantele din formulă, cum sunt: gentiopicrina, amarogentina, tanin, holozide, gentianina, gentisima, heterozide amare, vitaminele: A, B1, B2, PP, K, A, C și PP, pectine, fier, potasiu, magneziu, fosfor, rubidiu, siliciu, cupru, brom, zinc, mangan, mangan, calciu, sodiu, oxid de fier, clor, iod, arsenic, asparagină, betaină, glutamină, hiperină, hipericină, rutină, galactoză, flavonide, uleiuri volatile, cvercetrol, cvercitrină, colină, saponine, caroten, azulen, rezine, matricină, epigenină, umbeliferonă, picrosalvină, mirtilină, pectine, terpene, cineol, tuionă, camfor, borneol, levuloză, glucoza, acizi: nicotinic, malic, tartric, fosforic, citric, lactic, oxalic și succinic.The phytotherapeutic product according to the invention is based on active, natural substances existing in the plants of the formula, such as: gentiopicrin, amarogentin, tannin, holozides, gentianin, gentisima, bitter heterozygous, vitamins: A, B1, B2, PP, K, A, C and PP, pectin, iron, potassium, magnesium, phosphorus, rubidium, silicon, copper, bromine, zinc, manganese, manganese, calcium, sodium, iron oxide, chlorine, iodine, arsenic, asparagine, betaine, glutamine, hyperin, hypericin, routine, galactose, flavonids, volatile oils, cvercetrol, quercin, choline, saponins, carotene, azulene, resins, matrix, epigenin, umbeliferone, picrosalvin, myrtle, pectin, terpene, cineole, boron, camion, boron , glucose, acids: nicotinic, malic, tartaric, phosphoric, citric, lactic, oxalic and succinic.
Toate aceste substanțe active ducîn final la realizarea efectului scontat, de eliminare a efectelor produse de instalarea menopauzei în organismul uman și de stimulare a activității cerebrale și glandulare, ducând în final la o reglare normală a funcțiilor organismului uman.All these active substances eventually lead to the expected effect, eliminating the effects produced by the installation of menopause in the human body and stimulating the brain and glandular activity, finally leading to a normal regulation of the functions of the human body.
Pe lângă acțiunea principală a produsului conform invenției, de eliminare a efectelor cauzate de instalarea menopauzei, acesta este și un bun calmant, antihelmitic, antitermic, antiparazitar, antiastenic, antianemic, normalizează secrețiile biliare, antihepatic, antinevrotic, antituberculotic, antitumoral, antigripal, anticolitic, antiuiceros, calmant al vezicii biliare, activant al circulației sanguine, scade transpirația, energizant, remineralizant, detoxifiant, antiartritic, vitaminizant, carminativ, antihemoroidal, antireumatic, antiinfecțios și reglează funcția glandei tiroide.In addition to the main action of the product according to the invention, to eliminate the effects caused by the installation of menopause, it is also a good soothing, antihelmic, antithermal, antiparasitic, antiastenic, antianemic, normalizes the secretions biliary, antihepatic, antinevrotic, antituberculotic, antitumoral, antitumoral , anti-killer, gall bladder, blood circulation activator, decreases sweating, energizing, remineralizing, detoxifying, anti-arthritic, vitaminizing, carminative, anti-hemorrhoidal, anti-rheumatic, anti-infectious and regulates thyroid gland function.
Se cunoaște că, coarnele de cerb conțin, printre altele, o substanță care protejează fluidele organismului de enzimele distructive, lipide pentru crearea de celule și sporirea energiei, agenți puternici antiinflamatori, fosfor care ajută la consolidarea și creșterea oaselor și a dinților, magneziu pentru nervi și mușchi, și ajutarea celulelor să se refacă.It is known that deer horns contain, inter alia, a substance that protects the body's fluids from destructive enzymes, lipids for cell creation and energy boosting, powerful anti-inflammatory agents, phosphorus that help strengthen and grow bones and teeth, magnesium for nerves and muscle, and helping the cells recover.
Extractul din corn de cerb crește vitalitatea, alungă oboseala și are proprietăți spectaculoase împotriva îmbătrânirii. Se recomandă pentru îmbunătățirea vieții sexuale, creșterea calității sângelui, în anemie, hipertensiune și chiar creșterea tensiunii prea reduse, afecțiuni ale rinichilor, întărirea sistemului imunitar. Ca biosursă de minerale (Ca, Mg, P, Na și K), are rol important în metabolismul Ca-P, mai deține o gamă largă de elemente complexe, printre care aminoacizi, enzime, substanțe minerale, vitamine, lipide, hormoni feminini și masculini, hormonii importanți ai creșterii, ca IGF-1 și IGF-2 (un factor de creștere similar insulinei).The deer extract increases vitality, eliminates fatigue and has spectacular anti-aging properties. It is recommended for improving the sex life, increasing the quality of blood, in anemia, hypertension and even increasing the blood pressure too low, kidney disease, strengthening the immune system. As a mineral biosource (Ca, Mg, P, Na and K), it plays an important role in Ca-P metabolism, it also possesses a wide range of complex elements, including amino acids, enzymes, mineral substances, vitamins, lipids, female hormones and males, important growth hormones, such as IGF-1 and IGF-2 (an insulin-like growth factor).
Efectele benefice ale învelișului cornului de cerb, dovedite științific, sunt: ameliorează funcționarea sistemului imunitar, mărește performanța și puterea atleților, îmbunătățește regenerarea mușchilor după antrenamente, sursă naturală de substanțe nutritive, necesare sănătății femeilor, conferă vitalitate, supliment alimentar alternativ pentru culturiști, ajută în combaterea inflamațiilor articulațiilor și a poliartritei cronice, combaterea hipertensiunii, creșterea nivelului hemoglobinei, tratamentul ulcerului gastric, benefic în afecțiuni de prostată și anomalii de menstruație, scleroză multiplă, eczeme cronice, probleme de varice și poliartrită.The beneficial effects of scientifically proven deer shell cover are: they improve the functioning of the immune system, increase the performance and power of the athletes, improve the regeneration of the muscles after training, a natural source of nutrients, necessary for women's health, supplemental food, vitality supplement, food supplement in combating inflammation of the joints and chronic arthritis, combating hypertension, increasing hemoglobin level, gastric ulcer treatment, beneficial in prostate disorders and menstrual abnormalities, multiple sclerosis, chronic eczema, varicose veins and polyarthritis.
Asocierea, în rapoartele prestabilite, a plantelor indigene, prezintă o eficiență crescută, rezultată din potențarea reciprocă a componentelor între care există un efect sinergie, având drept rezultat o acțiune cumulată privind efectul susmenționat, dar efectul principal constă din ameliorarea evidentă a stării de sănătate a organismelor tratate, de durată și ireversibile, și fără efecte secundare.The association, in the pre-established reports, of the indigenous plants, presents an increased efficiency, resulting from the mutual enhancement of the components between which there is a synergistic effect, resulting in a cumulative action on the aforementioned effect, but the main effect consists in the obvious improvement of the health status of the plants. treated organisms, lasting and irreversible, and without side effects.
Astfel, constituenții care se potențează reciproc sunt: antioxidanții precum vitamina C din: anghinare, măceș, cătina, struguri negri, zmeur, coacăze-roșii; uleiuri volatile din: măceș, cătină, mușețel, sunătoare, ghințură, ventrilică, salvie, zmeur, coacăze roșii; flavonoide din: mușețel, ventrilică, anghinare, armurariu, zmeur; săruri minerale din: ghințură, anghinare, mușețel, struguri negri, salvie, coarne de cerb, zmeur, coacăze roșii, taninuri din: ghințură, struguri negri, ventrilică, zmeur; zaharuri din: anghinare, măceș, struguri negri;Thus, the constituents that enhance each other are: antioxidants such as vitamin C from: artichokes, mulberries, sea buckthorn, black grapes, raspberries, red currants; volatile oils of: rosehip, buckwheat, chamomile, ringworm, acorn, ventricle, sage, raspberry, red currant; flavonoids from: chamomile, ventricle, artichoke, armory, raspberries; mineral salts from: acorns, artichokes, chamomile, black grapes, sage, deer horns, raspberries, red currants, tannins from: acorns, black grapes, ventricles, raspberries; sugars: artichokes, blackberries, black grapes;
RO 127627 Β1 vitamina A din: anghinare, coarne de cerb, salvie; vitaminele B din: măceș, coarne de cerb, 1 anghinare, cătină; aminoacizi din: armurariu, zmeur; vitamina F din: struguri negri, coarne de cerb, zmeur, mușețel; saponine din: ventrilică, sunătoare; rășini din: zmeur, mușețel; dar 3 și alte substanțe ce potențează elementele susmenționate ca: gențiopicrina, amarogentina, gentisima, gentianina, acid gențiotanic, compuși uleioși, gentiamarină, gentiaculină, izo- 5 gentizină, steroli, lipide, gentianoză, gentiobioză, heterozide amare, cinarină, oxidaze, polifenoli, vitamina P, acid citric, acid malic, pectine, lecitină, vanilină, vitamina PP, acid folie, 7 acid nicotinic, inozitol, azulenă, matricină, acidul clorogenic, chamazulenă, substanțe amare de natură seseviterpenică, cumarină, colină, mucilagii, acid salicilic, fitosterine, substanțe 9 glicozidice, camilină, inositol, vitamina E, procianidine, acidul valerianic, colina, rutină, galactoză, hiperină, hipericină, glicozide, camfor, borneol, terpene, cineol, compuși estrogeni, 11 silimarina, cnicina, silibinina, silidianina, betaina chl, glicina, cisteina, leucina, tiramina, acid glutamic, fragarină, xilitol, proteine, auxine, gibbereline, citokine, enzime și emulsină. 13RO 127627 Β1 vitamin A from: artichokes, deer horns, sage; B vitamins from: mulberry, deer horns, 1 artichoke, sea buckthorn; amino acids from: armory, raspberries; Vitamin F from: black grapes, deer horns, raspberries, chamomile; saponins from: ventricular, sounding; resins from: raspberry, chamomile; but 3 and other substances that potentiate the aforementioned elements such as: gentiopyrin, amarogentin, gentisima, gentianin, gentianotinic acid, oily compounds, gentiamarine, gentiaculin, iso-5 gentizine, sterols, lipids, gentianosis, gentiobiosis, bitter heterozygous, cinarine, oxides, cinarine , vitamin P, citric acid, malic acid, pectin, lecithin, vanillin, vitamin PP, folic acid, 7 nicotinic acid, inositol, azulene, matrix, chlorogenic acid, chamazulene, bisexual substances of sevevpenenic nature, coumarin, choline, mucilages, acid salicylic, phytosterines, 9 glycosidic substances, camiline, inositol, vitamin E, procyanidins, valerianic acid, choline, rutin, galactose, hyperin, hypericin, glycosides, camphor, borneol, terpene, cineole, estrogen compounds, 11 silimarin, cnicine silidianine, betaine chl, glycine, cysteine, leucine, tyramine, glutamic acid, fragarine, xylitol, protein, auxin, gibbereline, cytokines, enzymes and emulsine. 13
Studiile medicale moderne demonstreză că valoarea de vitamina C, ce se asimilează în organism, are un rol determinantîn controlarea și îmbunătățirea capacității de a ne proteja 15 împotriva multor boli.Modern medical studies show that the value of vitamin C, which is assimilated into the body, plays a decisive role in controlling and improving our ability to protect ourselves against many diseases.
Acizii organici, cum ar fi acidul malic, acidul citric, pot ridica nivelul acidității sucului 17 gastric, ajutând digestia și reglând funcțiile stomacului și ale intestinelor, dar pot acționa și pentru prevenirea și tratamentul hiperlipidemiei, scăzând conținutul de colesterol din sânge. 19Organic acids, such as malic acid, citric acid, can increase the acidity level of gastric juice, aiding digestion and regulating the functions of the stomach and intestines, but they can also act to prevent and treat hyperlipidemia, lowering the cholesterol content in the blood. 19
TESTĂRI ENERGETICEENERGY TESTS
Comparația produsului revendicat, față de produsele A, B, C și D 21Comparison of the claimed product with respect to products A, B, C and D 21
Măsurătorile radiestezice au prezentat următoarele valori: produsul revendicat are 22.000 u.e., produsul A are 12.100 u.e., produsul B are 15.400 u.e., produsul C are 14.000 23The radiesthetic measurements showed the following values: the claimed product has 22,000 u.e., the product A has 12,100 u.e., the product B has 15,400 u.e., the product C has 14,000 23.
u.e., iar produsul D are 12.300 u.e. (u.e=unități energetice).u.e., and product D has 12,300 u.e. (u.e = energy units).
Acest test a fost coroborat cu testul ce privește efectul Kirlian, în care au fost, de 25 asemenea, testate aceste produsele, obținându-se următoarele rezultate: lungimea strimerilor măsurați pentru produsul revendicat a fost de 3,9...4,1 mm, pentru produsul A, de 27This test was corroborated with the test concerning the Kirlian effect, in which these 25 products were also tested, obtaining the following results: the length of the strimers measured for the claimed product was 3.9 ... 4.1 mm , for product A, of 27
2...2,2 mm, pentru produsul B, de 2,9...3,1 mm, pentru produsul C, este 2,3...2,5 mm, iar pentru produsul D, este de 1,9...2,1 mm. 292 ... 2.2 mm, for product B, 2.9 ... 3.1 mm, for product C, is 2.3 ... 2.5 mm, and for product D, it is 1, 9 ... 2.1 mm. 29
Concluzia este că produsul revendicat are o capacitate energetică între 42 și 81% mai mare decât produsele A, B, C și D, iar față de produsul D, față de care este cel mai 31 apropiat, capacitatea energetică este cu 25...32% mai mare, iar coroborat cu testul anterior, se poate observa că efectul terapeutic al produsului revendicat este sinergie și complex, cu 33 efect puternic asupra sistemului nervos și glandular, față de produsele prezentate.The conclusion is that the claimed product has an energy capacity between 42 and 81% higher than products A, B, C and D, and compared to product D, of which it is the closest 31, the energy capacity is 25 ... 32 % higher, and in conjunction with the previous test, it can be observed that the therapeutic effect of the claimed product is synergistic and complex, with 33 strong effects on the nervous and glandular system, compared to the presented products.
TESTĂRI CLINICE 35CLINICAL TESTS 35
A fost efectuată o evaluare a eficienței terapeutice a produsului revendicat, conform invenției, ca adjuvant în tratamentul diverselor tulburări privind instalarea efectelor cauzate 37 de menopauză.An evaluation of the therapeutic efficacy of the claimed product according to the invention was performed as an adjuvant in the treatment of various disorders related to the installation of the effects caused by menopause.
METODĂ 39 în perioada februarie - septembrie 2010, au fost monitorizate și urmărite clinic, la cabinetul de consultanță fitoterapeutică, un număr de 11 paciente, cu vârste cuprinse între 41 24 și 70 ani.METHOD 39 Between February and September 2010, 11 patients, ranging in age from 41 to 24 and 70, were clinically monitored and followed at the phytotherapeutic consultancy.
La cabinet, s-au prezentat diverse paciente cu menopauză instalată, din diverse 43 motive.At the clinic, there were various patients with menopause installed, for 43 different reasons.
Pacienele s-au prezentat cu documentația medicală completă (investigații para- 45 clinice), precum și schemele terapeutice alopate până la data respectivă.Toate pacienele au urmat terapiile alopate propuse, completându-le cu produsul revendicat. 47Patients were presented with the complete medical documentation (para-clinical investigations), as well as the allopathic therapeutic schemes up to that date. All patients followed the proposed allopathic therapies, supplementing them with the claimed product. 47
RO 127627 Β1RO 127627 Β1
De asemenea, au solicitat și acceptat completarea medicației cu un tratament fitoterapeutic, corespunzător afecțiunii lor. în urma prezentării pacienelor la cabinet și ca urmare a coroborării datelor anamnestice, clinice și paraclinice, s-a instituit tratamentul adjuvant cu produsul revendicat.They also requested and accepted the completion of the medication with a phytotherapeutic treatment, corresponding to their condition. Following the presentation of the patients to the office and as a result of the corroboration of the anamnestic, clinical and paraclinical data, the adjuvant treatment with the claimed product was instituted.
în urma administrării schemelor individuale de tratament (deoarece s-a ținut cont de afecțiunile acute, prezentate de fiecare), care au presupus însoțirea produsului urmărit cu alte suplimente alimentare, recomandate pentru respectivele afecțiuni acute, asociate, o mare parte dintre pacienți și-au reactualizat investigațiile clinice și paraclinice, astfel încât s-au putut compara observațiile clinice și datele de laborator constatate înainte și după tratamentul adjuvant cu produsul studiat.following the administration of the individual treatment schemes (because the acute conditions, presented by each one were taken into account), which involved the accompanying product with other dietary supplements, recommended for the respective acute, associated diseases, most of the patients have updated their investigations clinical and paraclinical, so that the clinical observations and laboratory data found before and after the adjuvant treatment could be compared with the product studied.
Perioada de monitorizare a fost de 90 zile, pacienele prezentându-se la control la fiecare 10 zile.The monitoring period was 90 days, patients presenting to the control every 10 days.
REZULTATERESULTS
Tratament pentru eliminarea efectelor menopauzeiTreatment to eliminate the effects of menopause
Au fost testate 4 tinere cu menopauză instalată devreme, aproximativ 24...26 ani, datorat stresului examenelor din facultate.4 young men were tested with menopause installed early, about 24 ... 26 years, due to the stress of the exams in the faculty.
Prin aplicarea tratamentului cu produsul revendicat, de 3 ori pe zi, câte o linguriță, timp de minimum 15.. .20 zile, până la 40 zile, s-a constatat eliminarea treptată a menopauzei și detensionarea sistemului nervos, dar și o schimbare a psihicului. S-a refăcut astfel traseul hipofiză-tiroidă-suprarenale și ovare. Produsul a fost bine tolerat.By applying the treatment with the claimed product, 3 times a day, one teaspoon, for a minimum of 15 .. .20 days, up to 40 days, it was found that the menopause was gradually eliminated and the nervous system relaxed, but also a change of the psychic. Thus, the pituitary-thyroid-adrenal and ovarian pathway was restored. The product was well tolerated.
Tratament privind eliminarea menopauzei testate pe 3 persoane, de vârstă medie,Treatment for eliminating menopause tested on 3 people, middle-aged,
40...48 ani40 ... 48 years
Prin investigații paraclinice, s-a constatat o scădere avansată și a mineralizării și vitaminizării din organism.Paraclinical investigations have shown an advanced decrease in mineralization and vitaminization in the body.
S-a constatat că menopauza s-a instalat, la aceste paciente, datorită evenimentelor emoționale negative, petrecute anterior.Menopause has been found to occur in these patients due to negative emotional events that occurred previously.
Prin aplicarea tratamentului cu produsul revendicat, de 3...4 ori pe zi, câte o linguriță, timp de minimum 2 săptămâni, până la 4 săptămâni, s-a constatat o ușoară eliminare și treptată menopauzei, ovarele reintrând în funcție normală, dar s-a observat și o eliminare a surplusului de greutate, cu aproximativ 0,5...1 kg pe săptămână, eliminarea transpirației abundente pe cap, constatându-se și rezolvarea altor probleme de sănătate, colaterale, precum și refacerea sistemului limfatic.Applying the treatment with the claimed product, 3 to 4 times a day, one teaspoon, for a minimum of 2 weeks, up to 4 weeks, a slight and gradual elimination of the menopause was observed, the ovaries returning to normal function, but it was observed and a elimination of the surplus of weight, with approximately 0.5 ... 1 kg per week, elimination of the abundant sweating on the head, finding and solving other health problems, collateral, as well as the restoration of the lymphatic system.
Tratament privind eliminarea menopauzei la femei în vârstă, 60...70 aniTreatment for menopause elimination in older women, 60 ... 70 years
Au fost testate 4 persoane cu menopauză instalată de mult timp.4 people have been tested for a long time with menopause.
Prin investigații paraclinice, s-a constatat o scădere a funcției sistemului nervos central, disfuncții ale glandelor hipofiză și hipotalamus.By paraclinical investigations, a decrease of the function of the central nervous system, dysfunctions of the pituitary glands and hypothalamus was found.
Prin aplicarea tratamentului cu produsul revendicat, de 3...4 ori pe zi, câte o linguriță, timp de minimum 4 săptămâni până la 6 săptămâni, s-a constatat o eliminare treptată a tensiunii nervoase, eliminarea transpirației abundente la cap, refacerea parțială a funcției ovariene, constatându-se și rezolvarea altor probleme de sănătate colaterale precum refacerea funcției circulatorii și eliminarea artritelor reumatoide. Răspunsul organismului la tratament a fost favorabil.By applying the treatment with the claimed product, 3 ... 4 times a day, one teaspoon, for a minimum of 4 weeks to 6 weeks, a gradual elimination of nervous tension, elimination of abundant sweating at the head, partial restoration of function ovaries, finding other collateral health problems such as restoring circulatory function and eliminating rheumatoid arthritis. The body's response to treatment was favorable.
CONCLUZIICONCLUSIONS
Rezultatele obținute la aceste pacientele diagnosticate cu probleme cauzate de instalarea menopauzei dovede faptul că folosirea produsului conform invenției, pentru tratarea diverselor probleme privind eliminarea transpirației, prezintă efect asupra glandelor sudoripare, dar având și proprietatea de refacere a funcției ovariene, prezintă numeroase beneficii.The results obtained in these patients diagnosed with problems caused by the installation of menopause prove that the use of the product according to the invention, for treating various problems regarding the elimination of perspiration, has an effect on the sweat glands, but also having the restoration of ovarian function, has many benefits.
Proprietățile produsului sunt datorate principiilor active din compoziție, care acționează sinergie, având totodată și efecte calmante. Nu s-au înregistrat reacții adverse în niciun caz.The properties of the product are due to the active principles of the composition, which act synergistically, also having calming effects. No adverse reactions were reported.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ROA201001260A RO127627B1 (en) | 2010-11-30 | 2010-11-30 | Product for eliminating the effects of menopause installation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ROA201001260A RO127627B1 (en) | 2010-11-30 | 2010-11-30 | Product for eliminating the effects of menopause installation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RO127627A2 RO127627A2 (en) | 2012-07-30 |
| RO127627B1 true RO127627B1 (en) | 2013-06-28 |
Family
ID=46575978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ROA201001260A RO127627B1 (en) | 2010-11-30 | 2010-11-30 | Product for eliminating the effects of menopause installation |
Country Status (1)
| Country | Link |
|---|---|
| RO (1) | RO127627B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240041905A1 (en) * | 2022-08-08 | 2024-02-08 | HuntGreenLiving LLC, DBA Nnabi | Oral composition for perimenopause |
-
2010
- 2010-11-30 RO ROA201001260A patent/RO127627B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO127627A2 (en) | 2012-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7069490B2 (en) | Yuricoma longifolia extract and its use in enhancing and / or stimulating the immune system | |
| CN105962359A (en) | Composition with function of assisting in improving memory | |
| Grigoriu et al. | Phytotherapy in obstetrics–therapeutic indications, limits, and dangers | |
| AU2022203588B2 (en) | Composition and methods and uses thereof | |
| EP2891496B1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX EXTRACT OF CRATAEGI FRUCTUS and CITRI PERICARPIUM AS AN ACTIVE INGREDIENT FOR TREATING OR PREVENTING OBESITY OR LIPID-RELATED METABOLIC DISEASES | |
| RO127627B1 (en) | Product for eliminating the effects of menopause installation | |
| RU2580282C1 (en) | Agent for preventing and treating urolithiasis | |
| RU2452507C1 (en) | Phytotranquiliser | |
| CN109954052A (en) | A kind of composition with antioxidant activity | |
| KR20190068990A (en) | Composition for relieving and healing menstrual pain containing fermented Celastrus orbiculatus | |
| KR0160402B1 (en) | Composition for prevention of stress | |
| RU2133096C1 (en) | Biologically active food addition "pari" and method of its use | |
| Bunce | The use of herbs in midwifery | |
| RO126833B1 (en) | Weight loss phytotherapy product | |
| BG113697A (en) | DIETARY SUPPLEMENT FROM MEDICINAL PLANTS FOR MYOMA | |
| RU2435451C1 (en) | Biologically active dietary supplement "eramin" dietary supplement origitea® antistress | |
| RO126369B1 (en) | Anti-asthenia and anti-hepatitis phytotherapeutic product | |
| RO127268B1 (en) | Antistress product | |
| CN108095067A (en) | A kind of preparation method alleviated visual fatigue and enhance memory capsule | |
| BG4456U1 (en) | Dietary supplement of medicinal plants beneficial in myoma conditions | |
| WO2024221062A1 (en) | Dietary supplement from medicinal plants in urticary and psoriasis | |
| RU2321275C2 (en) | Plant ingredient composition having gerontoprotective properties (versions) | |
| RO125953B1 (en) | PHYTOTERAPEUTIC PRODUCT INTENDED FOR THE DETOXIFICATION OF THE ORGANISM | |
| BG4461U1 (en) | Dietary supplement of medicinal plants beneficial in urticaria and psoriasis conditions | |
| RU2351350C1 (en) | Set "predstar", its application and method of prevention of premature organism aging |